MYH14 and neoplasm: The prevailing hypothesis regarding the pathophysiology of ICI-induced cardiotoxicity suggests that ICI inhibit certain muscle specific antigens such as against troponin, myosin or desmin, that are commonly shared between the tumor cells and cardiomyocytes, triggering a cross-reactive response with T cells targeting both the tumor and the cardiac muscle, resulting in immune related adverse events [49].